Accelerating the pace to clinic and beyond
As a viral vector CDMO, we break through barriers in cell and gene therapy by delivering high-quality, cost-effective and precise development, GMP viral vector manufacturing and testing services.
Solutions to propel your therapies forward
Whether you have a process defined or need guidance to identify the best path forward, we have the flexibility to support our customers wherever they are in their viral vector development journey. Keeping your growth front of mind, we tailor our solutions with the intent to get you to and through trial as quickly as possible.
Viral Vector Process Development
We support you in developing robust, scalable, and efficient processes to help you realize the potential of your therapy.Read more
GMP Vector Manufacturing
Unique expertise in GMP lentiviral and retroviral vector manufacturing, paired with a new state-of-the-art facility, we have the capacity and know-how to support your manufacturing needs.Read more
Cell Therapy Manufacturing
Leverage our world-class partnerships, streamline your production, and advance your cell therapy to trial and beyond.Read more
Connecting great discoveries with expert capabilities
We have the capacity, scalability, and reproducibility to accelerate your therapy. Learn more about our services.
What makes Genezen the right choice?
Client-centric guidance paired with complete viral vector development capabilities and GMP manufacturing capacity make us the perfect partner.
Time is of the essence when manufacturing viral vectors. We are continuously expanding to provide the essential and phased capacity that our customers need.
Everything we do is focused on accelerating your therapy to market. Our expertise and growth mindset help you move forward with confidence.
Our talented team and the added value of our world-class partnerships provide the essential experience to support lentivirus production.
State-of-the-art facility available
Retrovirus and lentivirus production availability
Specialists in retrovirus and lentivirus production, we can accelerate your therapy to commercialization and help you deliver life-changing therapeutics to patients.
Our new 75,000 square-foot facility in the fast-growing gene therapy hub of Indianapolis provides you with the essential capacity and latest technologies dedicated to the aseptic manufacture of lentiviral and retroviral vectors.
Explore Careers at Genezen
Do you have a passion to promote scientific advancement? Are you hungry to grow alongside and help shape a fast-developing, science-led CDMO? You may be a perfect fit for Genezen and we’d love to hear from you.